Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Jun 2019 Results of the DUET-Beta Extension Study (n=48) presented at the 79th Annual Scientific Sessions of the American Diabetes Association
05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes.
26 Jun 2018 Primary endpoint has not been met. (Comparing the two groups of change in beta-cell function over the 24-week treatment period, measured using the disposition index.) as per results presented at the 78th Annual Scientific Sessions of the American Diabetes Association

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com